Fresenius SE & Co. KGaA (FRE)

Index:

Xetra DAX

  42.62
   
  • Change Today:
     0.04
  • 52 Week High:  42.72
  • 52 Week Low:  27.52
  • Currency: Euro
  • Shares Issued: 563.24m
  • Volume: 1,092,939
  • Market Cap:  24,005m
  • Beta: 0.00

FRE Overview

Fresenius Medical Care offers services and products in the health care industry. Its main focus is kidney failure and dialysis products.

1 Day Chart (06-05-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 5.1%
ROCE 4.1%
Latest F'cast
P/E 62.1
PEG n/a
Pr/Revenue 1.0
Pr/Book 1.1
Latest F'cast
Revenue 3.6%
PBT -55.2%
EPS -69.3%
DPS -100.0%

FRE Fundamentals

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 35,409.00 3,912.00 338.00¢ 14.8 n/a 0% 84.00¢ 1.7%
31-Dec-20 36,277.00 3,726.00 306.00¢ 12.4 n/a -10% 88.00¢ 2.3%
31-Dec-21 37,520.00 3,652.00 326.00¢ 10.9 1.8 +6% 92.00¢ 2.6%
31-Dec-22 21,532.00 1,597.00 205.00¢ 12.8 n/a -37% 92.00¢ 3.5%
31-Dec-23 22,299.00 715.00 63.00¢ 44.6 n/a -69% n/a 0.0%

FRE Forecasts

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 22,708.81 2,568.22 326.21¢ 13.1 0.0 +418% 103.16¢ 0.0%
31-Dec-26 23,845.89 2,821.91 365.62¢ 11.7 1.0 +12% 112.54¢ 0.0%
31-Dec-27 25,052.05 3,016.45 393.53¢ 10.8 1.4 +8% 119.21¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

FRE Top Newspaper Links

Fresenius kauft Klinikbetreiber Humaine 21-Mar-2006 Die Welt

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

FRE Market Data

Currency Euro
Share Price   42.62
Change Today   0.04
% Change 0.09 %
52 Week High  42.72
52 Week Low  27.52
Volume 1,092,939
Shares Issued 563.24m
Market Cap  24,005m
Beta 0.00

What The Brokers Say

Strong Buy 10
Buy 7
Neutral 3
Sell 0
Strong Sell 0
Total 20
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page